Summary
Synergistic tumor-regressive activity was observed when the water-soluble portion of a phenol-water extract from mutant Salmonella typhimurium whole cells was combined with deproteinized cell walls from Mycobacterium bovis strain BCG. As little as 50 μg deproteinized cell walls combined with 50 μg water-soluble extract from the mutant salmonella produced 89–100% cures of line-10 dermal tumors in treated strain 2 guinea-pigs. However, none of the animals was cured following treatment with 50 μg of deproteinized cell walls alone. Only 17% of treated animals were cured following treatment with 50 μg of the water-soluble extract from the mutant salmonella. The deproteinized cell walls and water-soluble extract were suspended in oil-in-water emulsions and injected directly into 10 mm tumors. The deproteinized cell walls were prepared by treating BCG cell walls with proteolytic enzymes and denaturing agents (KCl, urea, Triton X-100, and guanidine hydrochloride). Urea or a combination of denaturing agents reduced the protein content of protease-treated cell walls from approximately 2% (w/w) protein to 0.7% protein. The antigenicity of the effectively deproteinized cell walls, as measured by skin testing in presensitized guinea-pigs, was reduced approximately ten-fold compared with untreated cell walls. Injection to mice of 500 μg deproteinized cell walls in combination with 500 μg water-soluble extract from the mutant salmonella produced transient, clinical signs of toxicity (malaise, conjunctivitis, diarrhea, and rough hair coats) lasting approximately 5 days. However, no deaths were observed. The synergistic antitumor effect of combining deproteinized BCG cell walls with the water-soluble extract from mutant salmonella may be useful for treatment of certain cases of spontaneous neoplastic disease.
Similar content being viewed by others
References
Azuma, I., Ribi, E. E., Meyer, T. J., Zbar, B.: Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J. Natl. Cancer Inst. 52, 95 (1974)
Berry, L. J.: Effect of endotoxins on the level of selected enzymes and metabolites. In: Bacterial Endotoxins. Landy, M. Braun, W. (eds.) p. 151. New Brunswick, N.J.: Rutgers University Press 1964
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., Williamson, B.: An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. 72, 3666 (1975)
Chapman, H. A., Jr., Hibbs, J. B., Jr.: Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science 197, 282 (1977)
Dische, Z.: New color reactions for determinations of sugars in polysaccharides. In: Methods of Biochemical Analysis. Glick, D. (ed.) Vol. 2, p. 313. New York: Interscience 1955
Haskins, W. T.: Spectrophotometric determination of fatty acid amides in lipides. Anal. Chem. 33, 1445 (1961)
Hibbs, J. B., Jr., Taintor, R. R., Chapman, H. A., Jr., Weinberg, J. B.: Macrophage tumor killing: influence of the local environment. Science 197, 279 (1977)
Higuchi, T., Hakamura, T., Uchino, H.: Effects of phenobarbital and endotoxin on the lethality and metabolism of 6-mercaptopurine in male BALB/c mice. Cancer Res. 37, 3668 (1977)
Hoffmann, M. K., Green, S., Old, L. J., Oettgen, H. F.: Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells. Nature 263, 416 (1976)
Lowry, D. H., Rosebrough, N. J., Farr, A. L., Randal, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
Marecki, N. M., Bradely, S. G.: Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs. Antimicrob. Agents Chemother. 3, 599 (1973)
McLaughlin, C. A., Ribi, E. E., Goren, M. B., Toubiana, R.: Tumor regression induced by defined microbial components in an oil-in-water emulsion is mediated through their binding to oil droplets. Cancer Immunol. Immunother. (in press 1978)
Meyer, T. J., Ribi, E. E., Azuma, I., Zbar, B.: Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J. Natl. Cancer Inst. 52, 103 (1974)
Rapp, H. J.: A guinea pig model for tumor immunology. Isr. J. Med. Sci. 9, 366 (1973)
Ribi, E., Meyer, T. J., Azuma, I., Zbar, B.: Mycobacterial cell wall components in tumor suppression and regression. Natl. Cancer Inst. Monogr. 39, 115 (1973)
Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., Strain, S. M.: Immunotherapy with nonviable microbial components. Ann. NY Acad. Sci. 177, 228 (1976a)
Ribi, E., Milner, K., Kelly, M. T., Granger, D., Yamamoto, K., McLaughlin, C. A., Brehmer, W., Strain, S. M., Smith, R. F., Parker, R.: Structural requirements of microbial agents for immunotherapy of the guinea pig line-10 tumor. In: BCG in Cancer Immunotherapy, p. 51. New York: Grune and Stratton 1976b
Ribi, E., Takayama, K., Milner, K., Gray, G. R., Goren, M., Parker, R., McLaughlin, C., Kelly, M.: Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure. Cancer Immunol. Immunother. 1, 265 (1976c)
Snodgrass, M. J., Hanna, M. G., Jr.: Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis. Cancer Res. 33, 701 (1973)
Suter, E., Kirsanow, E. M.: Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions. Immunology 4, 354 (1961)
Westphal, O., Lüderitz, O., Bister, F.: Über die Extraktion von Bakterien mit phenol/wasser. Z. Naturforsch. [C] 7b, 148 (1952)
Zbar, B., Ribi, E., Kelly, M., Granger, D., Evans, C., Rapp, H. J.: Immunologic approaches to the treatment of human cancer based on a guinea pig model. Cancer Immunol. Immunother. 1, 127 (1976)
Zbar, B., Ribi, E., Meyer, T., Azuma, I., Rapp, H. J.: Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. J. Natl. Cancer Inst. 52, 1571 (1974)
Zbar, B., Ribi, E., Rapp, H. J.: An experimental model for immunotherapy of cancer. Natl. Cancer Inst. Monogr. 39, 3 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McLaughlin, C.A., Bickel, W.D., Kyle, J.S. et al. Synergistic tumor regressive activity observed following treatment of line-10 hepatocellular carcinomas with deproteinized BCG cell walls and mutant Salmonella typhimurium glycolipid. Cancer Immunol Immunother 5, 45–52 (1978). https://doi.org/10.1007/BF00199207
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00199207